| Health / Medical Topics |
maytansinoid DM4-conjugated humanized monoclonal antibody huC242
Pronunciation
A substance being studied in the treatment of some types of cancer. It is made by linking the monoclonal antibody huC242 to a toxic substance called maytansinoid DM4. The monoclonal antibody binds to the surfaces of cancer cells and the maytansinoid DM4 enters the cells and blocks their growth. It is a type of immunotoxin. Also called huC242-DM4. (NCI Dictionary)
YOU MAY ALSO LIKE
Any of a class of anti-mitotic compounds that bind to the maytansine site of the beta tubulin subunit, a region that appears…
An ansamycin antibiotic originally isolated from the Ethiopian shrub Maytenus serrata. Maytansine binds to tubulin at the rhizoxin binding site, thereby inhibiting…
A country in southern Africa, occupying an island in the Mozambique Channel, about one-half of the way from northern Madagascar to northern…
A chemotherapy combination used to treat colorectal cancer. It is also used with radiation therapy to treat esophageal cancer and stomach…
The Mayo Clinic Cancer Center is dedicated to understanding the biology of cancer, to discovering new ways to predict, prevent, diagnose and…
The determination of the amount of May-Hegglin anomaly present in a blood sample.
